APTX.TO Apotex Health Corp

Healthcare Drug Manufacturers - Specialty & Generic Toronto Exchange
34.48 CAD
Close of Nov 7, 2026
26.01 40.11
Market cap
CAD 7.88B
P/E
-
P/B
21.99x
ROE
-43.8%
Dividend yield
14.08%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is APTX.TO undervalued?

Graham number

The Graham number of Apotex Health Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Apotex Health Corp fundamental analysis

No fundamental analysis for Apotex Health Corp yet.

Apotex Health Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Apotex Health Corp

Apotex Health Corp. operates as a pharmaceutical manufacturing company in Canada, the United States, Mexico, and India. The company develops, manufactures, and distributes a portfolio of prescription and generic pharmaceuticals, oncology biosimilar pharmaceuticals, branded specialty pharmaceuticals, and branded consumer health and wellness products. Apotex Health Corp. has a strategic partnership with Halo Pharmaceutical, Inc. The company was formerly known as Artemis Parent…

Full company profile